New Key Statistics Module, Z-Score and F-Score
OTCPK:SLNCF Key Ratios
| Market Cap $ M | 1,171.63 |
| Enterprise Value $ M | 1,055.12 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 7.41 |
| Price/Sales | 29.89 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 33.00 |
| EPS (TTM) $ | -0.39 |
| Beneish M-Score | -2.04 |
| 10-y EBITDA Growth Rate % | -11.40 |
| 5-y EBITDA Growth Rate % | -10.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -20.89 |
| EV-to-EBITDA | -21.15 |
| PEG | -- |
| Shares Outstanding M | 139.98 |
| Net Margin (%) | -131.73 |
| Operating Margin % | -156.68 |
| Pre-tax Margin (%) | -154.52 |
| Quick Ratio | 12.82 |
| Current Ratio | 12.82 |
| ROA % (ttm) | -30.60 |
| ROE % (ttm) | -91.84 |
| ROIC % (ttm) | -132.52 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.69 |
SLNCF Number of Guru Trades
SLNCF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SLNCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SLNCF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Silence Therapeutics PLC Insider Transactions
No Available Data
News about OTCPK:SLNCF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers